Tag Archive: Collaborations

TRC Events


Drugs, Biologics, Vaccines and Devices June 2, 2017 New Approaches to Metabolomics Research The ICTR Drugs/Biologics/Vaccines Devices Translational Research Community and the Center for Metabolomics Analysis are hosting a symposium on June 2 from 9:30am-12:30pm in Tilghman Auditorium at the Miller Research Building, 733 North Broadway.  Event check-in and coffee service will begin at 9:00am. The program will run 9:30am-12:30pm. Upon exciting the event, attendees may pick up a boxed lunch and meet with core leaders and other experts. All faculty and staff are encouraged to attend. Speakers will address the following topic areas: Resources available on campus: The Metabolomics Program as part … Continue reading

Patient Safety Collaborative


  We are working with Johns Hopkins Whiting School of Engineering to establish an “Engineering Collaborative for Patient Safety” to bring engineering talent to clinicians so they may solve patient safety issues. This collaborative is an effort of the Master of Science in Engineering Management (MSEM) program at Johns Hopkins Whiting School of Engineering, the Armstrong Institute for Patient Safety and Quality, Johns Hopkins Home Care Group, the Welch Center for Prevention, Epidemiology and Clinical Research, and the Johns Hopkins Hospital Clinical Engineering Services. If you have an idea, project, or site that you think could benefit from a team … Continue reading

Johns Hopkins and Kaiser Permanente Research Collaboration Committee


Mission The purpose of this committee is to foster and promote synergistic research between Kaiser Permanente and Johns Hopkins Medicine.  Research represents a particular synergistic opportunity with potential for broad impact inside and outside both organizations.  The work of the collaboration will concentrate on fostering research that will benefit both organizations and present the opportunity for much broader impact—changing the way medicine is practiced and associated healthcare policies. To learn more about this collaboration, visit https://jhkpresearch.johnshopkins.edu/

Collaborations


The ICTR plans a variety of activities to promote interactions of clinical, translational and basic scientist trainees across Johns Hopkins. We commit to continued cooperation with the NIH and other CTSA programs.

Reading Hospital/Tower Health


Reading Hospital/Tower Health  includes Reading Hospital, a 647-bed acute care hospital located in West Reading, Pennsylvania, and Reading Health Rehabilitation Hospital, a facility in Spring Township, featuring a 50-bed skilled nursing unit and a 62-bed inpatient rehabilitation unit. The health system also provide office-based primary and specialty care through Reading Health Physician Network, in-home nursing care through Reading Health Home Care, and retirement living through The Highlands at Wyomissing. An extensive network of outpatient services are provided through offices and QuickCare walk-in centers throughout the region. In addition to offering state-of-the-art care, the health system has created an environment that … Continue reading

Anne Arundel Health System


Anne Arundel Medical Center (AAMC), a regional health system headquartered in Annapolis, Md., serves an area of more than one million people. Founded in 1902, AAMC includes a 385-bed not-for-profit hospital, a medical group, imaging services, a substance use treatment center, and other health enterprises. In addition to a 57-acre Annapolis campus, AAMC has outpatient pavilions in Bowie, Kent Island, Odenton and Waugh Chapel. Clinical Research at Anne Arundel Medical Center starts with the dedicated physicians, nurses, and other medical professionals whose interests include the advancement of medical science. It comes together with the support of our team of professional … Continue reading

Peninsula Regional Medical Center


Peninsula Regional Medical Center (PRMC) in Salisbury, Maryland offers the widest array of specialty and subspecialty services on the Delmarva Peninsula. At 275 acute care beds, PRMC is the region’s largest, most advanced tertiary care facility, and has been meeting the healthcare needs of Delmarva Peninsula residents since 1897. Its 3,300 physicians, staff and volunteers provide safe, compassionate and affordable care designed to exceed the expectations of the nearly 500,000 patients who rely on the Medical Center team each year for inpatient, outpatient, diagnostic, subacute and emergency/trauma services. It is the region’s oldest healthcare institution with the most experienced team … Continue reading

Inova Health System


The addition of Inova Health System of Northern Virginia and its five major hospitals provides yet another strength to the Johns Hopkins Clinical Research Network in terms of established research programs, patient population and specialty collaborations, especially in the area of pediatrics, neurosciences, cardiovascular, oncology and genomics medicine. Dr. John E. Niederhuber, Inova’s EVP and CEO of the Inova Translational Medicine Institute and Professor of Oncology and Surgery at the Johns Hopkins University School of Medicine, is co-director of the Johns Hopkins Clinical Research Network and sits on the Executive Committee of the JHCRN. Dr. Niederhuber was formerly Director of … Continue reading

For Sponsors


The Johns Hopkins Clinical Research Network offers industry a unique opportunity to conduct clinical research studies in the Mid Atlantic U.S. region. The following Frequently Asked Questions are intended to provide information for sponsors.

2. Who should sponsors and CROs contact if interested in bringing a study to the JHCRN?

The Johns Hopkins Clinical Research Network can be contacted by any of the following:

• Website: http://ictr.johnshopkins.edu/service/JHCRN
• Phone: 443-287-4000
• E-mail: jhcrn@jhmi.edu
• Director: Dr. Adrian Dobs: adobs@jhmi.edu
• Co-director: Dr. John Niederhuber: John.Niederhuber@inova.org.

3. What information should sponsors and CROs provide for the JHCRN to consider a study?

a. Study information (title, synopsis, patient population, eligibility criteria),
b. Funding information (if available),
c. Confidentiality Disclosure Agreement (CDA) template, and
d. Feasibility questionnaire.

4. How do JHCRN sites decide which studies they would like to participate in?

Each site will review study materials and make a decision regarding their participation based on the following criteria:

• Study population,
• Site resources,
• Investigator interest and experience,
• Protocol complexity, and
• Funding

5. What are the benefits of using the JHCRN?

• One dedicated experienced Network Coordinator for each JHCRN site,
• Access to a large and diverse pool of patients,
• One prime contract with Johns Hopkins,
• One main IRB, Johns Hopkins Medicine IRB, and
• One budget.

6. What is the Network Coordinator role?

Each JHCRN site has an assigned network coordinator who liaisons between the Johns Hopkins investigator, JHCRN site investigator, and their respective research teams. Responsibilities include:

• Facilitating the identification, prioritization, and implementation of clinical trials jointly approved by JH and network site investigators,
• Developing and implementing effective workflow processes between JHU and the network site in opening research studies, and
• Serving as a main point of contact for both institutions.

7. How do sponsors and CROs identify a principal investigator for a study?

A JHCRN network coordinator can help you identify a JHU principal investigator. Coordinator contact information can be found at: http://ictr.johnshopkins.edu/clinical/clinical-resources/human-subjects-research-core/jhcrn/jhcrn-network-coordinators/.

8. Does each JHCRN site have its own principal investigator?

There is one principal investigator for each study who is a Johns Hopkins employee. A lead site investigator is designated at each JHCRN site who is accountable for local study oversight under the direction of the Johns Hopkins principal investigator.

9. Does the JHCRN have a site management plan?

Yes. It is available upon request.

10. How does the principal investigator oversee study conduct at JHCRN sites?

The Johns Hopkins principal investigator and lead site investigator(s) communicate regularly about all study activities to ensure quality and integrity of each study.

11. Who takes responsibility for reporting adverse events from the Network sites to IRB, sponsor, and other regulatory agencies?

The site investigator notifies the principal investigator (PI) of any event meeting expedited reporting requirements as soon as possible. Event reporting to sponsor will first be completed by the principal investigator or site investigator. The PI will determine this reporting responsibility at the onset of a study, and also report to the JHM IRB, and other regulatory agencies as required.

12. Who does the sponsor and CRO correspond with at the affiliate sites, the JHCRN network coordinator or research staff?

Prior to study start-up, the network coordinator will be the main point of contact to help research staff get started. The network coordinator may have some contact with the sponsor/CRO after start up, but it is preferred they correspond with the research staff directly.

13. Do sponsors and CROs negotiate budgets and contracts with each JHCRN site?

No. There is one budget and one contract between sponsor and JHU that includes costs for the JHU principal investigator and JHCRN site(s). A JHU budget specialist develops and negotiates all study budgets for the JHCRN.

15. Where does monitoring take place and where are regulatory documents kept?

Routine study monitoring occurs at both the main Johns Hopkins central site as well as at each participating JHCRN site. The sponsor’s monitor arranges visits with individual sites on mutually convenient dates. Regulatory documents are maintained by the PI’s team at Johns Hopkins for all participating JHCRN sites.

16. Who ensures research staff at JHCRN sites are appropriately trained in the conduct of human subjects’ research?

The Johns Hopkins Medicine IRB requires human subjects research compliance training, both initial and continuing, be completed by each investigator and other study team member(s).

-->

Behavioral, Social and Systems Science


The Behavioral, Social, and Systems Science community is lead by co-leaders Felicia Hill-Briggs and Jill Marsteller. The Behavioral, Social, and Systems Science (BSSS) community is designed to create an academic home and collaborative community for diverse scientists from across Johns Hopkins University who are conducting research in the areas of health and behavior, biopsychosocial interactions, social and cultural factors in health, health systems and health services, health IT, and methodologies. The BSSS Community serves as a catalyst to stimulate highly innovative researchers and research programs that expand the translation and dissemination of this research, and facilitate new methodologies for solving … Continue reading

Biomarkers and Diagnostic Testing


The Biomarkers and Diagnostic Tests community is lead by co-leaders Martin Pomper and Elizabeth Selvin. Diagnostic imaging has become the cornerstone of patient evaluation and therapy for many medical conditions. While the opportunities for research in imaging are limitless, most of our research activities can be categorized into the broad areas of imaging in the assessment of pharmacological and therapeutic modifiers of disease; assessment of new imaging technologies and methods; and image guided therapy. ​Advances in imaging technology benefit society as a whole and as such this community strives to build and sustain collaborative working relationships with many JHU departments, centers, … Continue reading